Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,445.00
Bid: 1,435.00
Ask: 1,437.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.139%)
Open: 1,485.00
High: 1,485.00
Low: 1,410.00
Prev. Close: 1,445.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Down After Biden Aid Plan; US Bank Results Due

Fri, 15th Jan 2021 12:15

(Alliance News) - Stock prices in London continued to slide at midday on Friday as investors scrutinised the hefty economic stimulus proposals in the US of the incoming Biden administration amid concern that equally hefty tax increases could be on the cards.

US President-elect Joe Biden will propose injecting USD1.9 trillion into the economy when he takes office next week, as evidence mounts that the recovery from the sharp downturn caused by Covid-19 is flagging.

Dubbed the American Rescue Plan, the proposal released Thursday includes a host of measures aimed at revitalising the world's largest economy.

The plans include an extra USD1,400 cash handout for individuals - to top up the USD600 in last month's stimulus - a hike in the minimum wage to USD15 an hour, and billions of dollars to ramp up vaccinations so that 100 million are administered in 100 days.

Top Senate Democrat Chuck Schumer and House Speaker Nancy Pelosi embraced Biden's plan, vowing to put it before lawmakers.

With his Democrats narrowly controlling both houses of Congress, Biden has a shot at passing what would be a third massive pandemic aid package. But the impending trial of Trump in the Senate will introduce a potentially nightmarish mix of scheduling complications and political drama.

In London on Friday, the FTSE 100 index was down 55.37 points, or 0.9%, at 6,746.59. The mid-cap FTSE 250 index was down 222.76 points, or 1.2%, at 20,552.99. The AIM All-Share index was down 0.8% at 1,173.16.

The Cboe UK 100 index was down 0.7% at 671.85. The Cboe 250 was down 1.0% at 17,810.11, and the Cboe Small Companies was down 0.3% at 12,300.56.

In Paris, the CAC 40 was down 0.9%, while Frankfurt's DAX 30 was 0.7% lower.

"Joe Biden has now released details of his proposed USD1.9 trillion stimulus plan and while positive for helping to revive the US economy, financial markets have already priced in the good news and are now starting to worry about the negative side, namely how it will be funded. The large scale of the proposed support measures adds fuel to the fire that taxes and interest rates will have to go up. Both have negative connotations for equities, therefore casting a cloud on the ability for stock markets to keep rallying at the same pace they have enjoyed for much of 2021," said AJ Bell's Russ Mould.

On the London Stock Exchange, Aveva Group was the best blue-chip performer at midday, up 5.1% after the industrial software company said its third-quarter revenue was boosted by contract renewals.

In the three months to December 31, organic constant currency revenue grew by more than 26%. Following the "strong quarter of renewals", Aveva's revenue in the nine months ended December grew 1.5% annually, on an organic constant currency basis.

"The board remains confident in the full year outlook for Aveva. Notwithstanding the disruption seen to the trading environment in 2020, the trend towards the digitalisation of the industrial world is strong and the board remains excited about the significant growth opportunities ahead," the company said.

In the FTSE 250, Indivior was the best performer, up 9.0% after the drugmaker raised its 2020 revenue guidance to a range between USD645 million and GBP650 million from a previous guided range of USD595 million to GBP620 million.

In addition, Indivior lifted its 2020 net revenue guidance for opioid-addiction drug Sublocade to USD128 million to GBP130 million from USD120 million to GBP125 million. As such, Indivior expects to deliver adjusted pretax profit ahead of its previous expectations.

At the other end of the midcaps, Petrofac was the worst performer, down 21% after the UK's Serious Fraud Office late Thursday said a former executive of the oilfield services company pleaded guilty to three counts of bribery.

Petrofac noted on Friday that no charges were brought against the company or any other officers and employees. In connection with the SFO's ongoing investigation into Petrofac, David Lufkin, its former global head of sales, on Thursday pleaded guilty at Westminster Magistrates' Court to three counts of bribery.

"A small number of former Petrofac employees are alleged to have acted together with the individual concerned, although none have been charged. No current board member of Petrofac Ltd is alleged to have been involved," the company said on Friday.

The offences relate to corrupt offers and payments made between 2012 and 2018 to influence the award of contracts to Petrofac in the United Arab Emirates worth approximately USD3.3 billion, the SFO said in a statement on Thursday.

Babcock International was down 17% after the defence contractor said the civil aviation market continued to struggle in its third quarter, as the sector was hit by a resurgent Covid-19, with prospects for its traditionally bumper final stretch of trading also uncertain.

Further, in a worrying update on a "review of contract profitability and balance sheet", Babcock cautioned on possible write-downs and continued to withhold financial guidance.

Underlying revenue for the nine months to December 31 was GBP3.40 billion, down 4.9% from GBP3.57 billion a year earlier. Babcock said that excluding disposals and foreign exchange, revenue was down 3%. Underlying operating profit for the nine months was down 37% annually to GBP202 million from GBP320 million, or down 34% excluding currency changes and disposals.

The pound was quoted at USD1.3646 on Friday at midday, lower from USD1.3681 at the London equities close Thursday, after data showed the UK economy shrank in November, sparking fears of a double-dip recession.

On a monthly basis, the UK gross domestic product shrank 2.6% in November after posting 0.6% growth in October, as restrictions were in place to varying degrees across all four nations of the UK during November.

Robert Alster, Chief Investment Officer at Close Brothers Asset Management said: "General consensus is that the UK economy is going to get worse before it gets better, which is reflected in November's GDP plummet after several months of tentative growth. The lockdown at the end of 2020 almost feels like old news as we undergo our third round of shutdown.

"A double dip recession is increasingly on the cards for Britain. Virus cases continue to climb, leaving policy-makers grappling with establishing an effective health policy whilst providing enough financial support for both individuals and businesses. With no set end-date for the current restrictions, investors will be hoping that the rapid vaccine roll out programme across the nation will get the UK economy up and running again, meaning there is light at the end of the tunnel."

The euro stood at USD1.2130, down from USD1.2145. Against the yen, the dollar was trading at JPY103.64, lower from JPY103.72.

Brent oil was trading at USD55.51 a barrel at midday, down from USD55.69 a barrel at the London equities close Thursday. Gold was priced at USD1,852.44 an ounce, higher than USD1,847.36.

US stock market futures were pointed to a lower open ahead as earnings season begins in earnest, with fourth-quarter results from Wall Street titans JPMorgan Chase, Citigroup and Wells Fargo.

The Dow Jones Industrial Average was called down 0.4%, the S&P 500 down 0.5% and the Nasdaq Composite down 0.3%.

"Traders will be most interested in the guidance from the US banks and what company executives are saying about the prospects for 2021 overall. With analysts forecasting a sharp pickup in growth as highly-effective COVID-19 vaccines roll out across the globe, traders will want to hear corresponding optimism from top US bankers," said Forex.com analyst Matthew Weller.

Friday's economic calendar has US retail sales at 1330 GMT followed by US industrial production at 1415 GMT.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
24 Jun 2022 12:40

IN BRIEF: Indivior settles patent infringement case with DRL

Indivior PLC - Richmond, Virginia-based pharmaceutical firm - Enters into a settlement agreement with Indian pharmaceutical company Dr Reddy's Laboratories Ltd and its subsidiaries together with Aquestive Therapeutics Inc. Explains that the settlement is for a patent infringement case regarding DRL's generic buprenorphine and naloxone sublingual film that is equivalent to its Suboxone sublingual film.

Read more
24 Jun 2022 12:11

Indivior settles patent litigation with Dr. Reddy's

(Sharecast News) - Opioid addiction treatment maker Indivior has settled a patent infringement case with generic drug maker Dr. Reddy's Laboratories.

Read more
1 Jun 2022 19:41

TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
3 May 2022 09:48

Indivior commences USD100 million share buyback programme

(Alliance News) - Indivior PLC on Tuesday said it has commenced a share buyback programme for up to USD100 million, signing a non-discretionary agreement with Stifel Nicolaus Europe Ltd in relation to the programme.

Read more
28 Apr 2022 16:04

UK shareholder meetings calendar - next 7 days

Friday 29 April  
ADVFN PLCGM re director appointments
AstraZeneca PLCAGM
BBGI Global Infrastructure SAAGM
GreenCoat Renewables PLCAGM
Holders Technology PLCAGM
HSBC Holdings PLCAGM
JPMorgan Claverhouse Investment Trust PLCAGM
Kingspan Group PLCAGM
Minoan Group PLCAGM
Nostrum Oil & Gas PLCGM - re notes restructuring
Pearson PLCAGM
Photo-Me International PLCAGM
Rotork PLCAGM
Smurfit Kappa Group PLCAGM
Travis Perkins PLCAGM
Monday 2 May 
no events scheduled 
Tuesday 3 May 
AVI Japan Opportunity Trust PLCAGM
CPPGroup PLCAGM
F&C Investment Trust PLCAGM
IOG PLCAGM
Plus500 LtdAGM
Smithson Investment Trust PLCAGM
Wednesday 4 May 
Barclays PLCAGM
Caledonia Mining Corp PLCAGM
CentralNic Group PLCAGM
GlaxoSmithKline PLCAGM
Just Eat Takeaway.com NVAGM
Ocado Group PLCAGM
RIT Capital Partners PLCAGM
Safestyle UK PLCAGM
Standard Chartered PLCAGM
Ten Entertainment Group PLCAGM
Tribal Group PLCAGM
Tritax Big Box REIT PLCAGM
Unilever PLCAGM
Thursday 5 May 
AIB Group PLCAGM
Alpha FX Group PLCAGM
Apax Global Alpha LtdAGM
Ascential PLC AGM
Avast PLCAGM
BAE Systems PLCAGM
Ceres Power Holdings PLCAGM
Clarkson PLCAGM
Costain Group PLCAGM
Domino's Pizza Group PLCAGM
EJF Investments LtdEGM re rollover offer
Emis Group PLCAGM
GetBusy PLCAGM
Glanbia PLCAGM
Griffin Mining LtdAGM
IMI PLCAGM
Indivior PLCAGM
James Fisher & Sons PLCAGM
Jardine Matheson Holdings LtdAGM
John Wood Group PLCAGM
KRM22 PLCAGM
Made.com Group PLCAGM
Melrose Industries PLCAGM
Mincon Group PLCAGM
MoneySupermarket.com PLCAGM
Morgan Advanced Materials PLCAGM
Morgan Sindall Group PLCAGM
Personal Group Holdings PLCAGM
Quixant PLCAGM
Rathbones Group PLCAGM
Reach PLCAGM
Scotgems PLCAGM
Witan Investment Trust PLCAGM
Sancus Lending Group LtdAGM
React Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Apr 2022 11:59

Indivior set to meet full-year guidance; announces buyback

(Alliance News) - Indivior PLC said on Thursday its strong start to 2022 had put it on track to meet its annual guidance as the company also announced a new USD100 million buyback.

Read more
28 Apr 2022 07:53

Indivior maintains guidance after 'strong start' to year

(Sharecast News) - Pharmaceuticals firm Indivior reported first quarter net revenue of $207m (£165.07m) in an update on Thursday, up 15% year-on-year, as it maintained its guidance for the full year.

Read more
4 Apr 2022 09:47

LONDON BROKER RATINGS: Barclays downgrades Aviva and raises Just Group

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
31 Mar 2022 15:26

Indivior starts formal shareholder talks over additional US listing

(Sharecast News) - Opioid addiction treatment maker Indivior said on Thursday that it is beginning formal consultations with shareholders about a potential additional listing of its shares in the US.

Read more
25 Mar 2022 09:46

LONDON BROKER RATINGS: Next and B&M raised; British Land cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
25 Mar 2022 08:20

LONDON BRIEFING: Petropavlovsk warns bank sanctions to hit gold sales

(Alliance News) - Russian gold miner Petropavlovsk on Friday warned it has a USD200 million term loan and a USD86.7 million revolving credit facility with Gazprombank, a bank which now has been sanctioned by the UK, in the wake of Russia's invasion of Ukraine.

Read more
15 Mar 2022 16:49

DIRECTOR DEALINGS: Indivior chief HR officer sells; Volex COO buys

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:

Read more
18 Feb 2022 14:17

IN BRIEF: Indivior strategy chief Simkin sells GBP800,000 in shares

Indivior PLC - North Chesterfield, Virginia-based treatments for opioid addiction - Chief Commercial & Strategy Officer Richard Simkin sells 300,000 shares at GBP2.70, worth GBP810,000, on Thursday. The sale represented just under half of his Indivior shareholding, retaining 340,025 shares. Indivior on Wednesday had reported a swing to profit in 2021 and said it is considering a US share listing.

Read more
16 Feb 2022 17:06

LONDON MARKET CLOSE: Stocks edge lower on doubts over Russia pullback

(Alliance News) - Stocks in London on Wednesday ended on a subdued note amid doubts over the reported pullback of Russian forces from the Ukraine borders.

Read more
16 Feb 2022 12:02

LONDON MARKET MIDDAY: Stocks struggle as NATO doubts Russia withdrawal

(Alliance News) - European equities were mixed midday Wednesday as a tense situation on the Ukraine border and a staggering UK inflation figure saw trepidation creep in, with markets surrendering earlier gains.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.